Cell > Point
Manufacturing · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7120 E Orchard Rd Ste 350, Centennial, C...Phone Number
(303) 689-9693Website
www.cellpointweb.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cell > Point
CellPoint is a biopharmaceutical company focused on the development of universal molecular imaging compounds and molecular therapeutics for the diagnosis, staging, treatment and treatment monitoring of cancer, cardiovascular disease, and a range of ischemic diseases. CellPoint has exclusive licenses to five drug-development platforms, all from The University of Texas MD Anderson Cancer Center in Houston, a world leader in cancer research and care. CellPoint has 59 patents issued for Oncardia®, 14 patents pending, and is filing additional patents based on the new organic formulation including the one vial kit.Explore more
Cell > Point Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cell > Point your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Cell > Point recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Cell > Point had a recent Job posting/layoffs
Check out if Cell > Point is spiking on competitors!
Cell > Point, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Cell > Point has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Cell > Point
Product Launch: Get notified when Cell > Point launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Cell > Point has new funding data
Recommended Actions
Find VP level buyers at Cell > Point
Find 3 more new buyers
Compare Similar Companies to Cell > Point
Compare insights from companies similar to Cell > Point, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cell > Point is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cell > Point is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cell > Point.
Cell > Point financials insights
Gather financial insights about Cell > Point, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$76K
Cell > Point Tech Stack
A closer look at the technologies used by Cell > Point
Cell > Point News & Media
CellPoint Plans to Complete Phase 2b Trial in Evaluating the Presence and Severity of Coronary Artery Disease
CENTENNIAL, Colo., May 17, 2019 /PRNewswire/ -- CellPoint announced today that it plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in patients suffering from coronary artery disease using the company's new one-vial Oncardia® (ethylenedicysteine-glucosamine) ...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cell > Point
Sign Up For FreeTo access detailed company insights
CellPoint is a biopharmaceutical company focused on the development of universal molecular imaging compounds and molecular therapeutics for the diagnosis, staging, treatment and treatment monitoring of cancer, cardiovascular disease, and a range of ischemic diseases. CellPoint has exclusive licenses to five drug-development platforms, all from The... Read More
